
|Articles|April 19, 2007
Dr. von Eschenbach receives distinguished service award
FDA Commissioner Andrew C. von Eschenbach, MD, recently received the American Association for Cancer Research Distinguished Service Award for exemplary leadership as director of the National Cancer Institute during a time of flourishing scientific and technological advances with gradually diminishing resources.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
3
Benjamin Lowentritt, MD, reviews real-world testosterone recovery data with relugolix
4
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
5











